Detalhe da pesquisa
1.
Validation of the new comprehensive cytogenetic scoring system (NCCSS) on 630 consecutive de novo MDS patients from a single institution.
Am J Hematol
; 88(2): 120-9, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23349006
2.
Does cytogenetic evolution have any prognostic relevance in myelodysplastic syndromes? A study on 153 patients from a single institution.
Ann Hematol
; 89(6): 545-51, 2010 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-20217086
3.
Clinical relevance of cytogenetics in myelodysplastic syndromes.
Ann N Y Acad Sci
; 1089: 395-410, 2006 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-17261783
4.
ABL1 amplification in T-cell acute lymphoblastic leukemia.
Cancer Genet Cytogenet
; 162(2): 146-50, 2005 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-16213363
5.
Molecular genetics of acute myeloid leukemia.
Ann N Y Acad Sci
; 963: 297-305, 2002 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-12095955
6.
Molecularly targeted therapy in acute myeloid leukemia.
Ann N Y Acad Sci
; 1028: 409-22, 2004 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-15650266
7.
Detection of TET2 abnormalities by fluorescence in situ hybridization in 41 patients with myelodysplastic syndrome.
Cancer Genet
; 205(6): 285-94, 2012 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-22749034
8.
Long-term follow up with conventional cytogenetics and band 13q14 interphase/metaphase in situ hybridization monitoring in monoclonal gammopathies of undetermined significance.
Br J Haematol
; 118(2): 545-9, 2002 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-12139743